Journal article

Elevated peripheral expression of neuregulin-1 (NRG1) mRNA isoforms in clozapine-treated schizophrenia patients

Md Shaki Mostaid, Ting Ting Lee, Gursharan Chana, Suresh Sundram, Cynthia Shannon Weickert, Christos Pantelis, Ian Everall, Chad Bousman

Translational Psychiatry | NATURE PUBLISHING GROUP | Published : 2017

Grants

Awarded by National Health and Medical Research Council of Australia


Awarded by National Health and Medical Research Council (Australia) Principal Research Fellowship (PRF)


Awarded by NHMRC Senior Principal Research Fellowship


Awarded by NHMRC


Awarded by Brain and Behavior Research Foundation (NARSAD)


Funding Acknowledgements

We acknowledge the financial support of the CRC for Mental Health. The Cooperative Research Center (CRC) program is an Australian Government Initiative. We also wish to acknowledge the CRC Scientific Advisory Committee, in addition to the contributions of study participants, clinicians at recruitment services, staff at the Murdoch Children's Research Institute, staff at the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Aging, and research staff at the Melbourne Neuropsychiatry Center, including coordinators Phassouliotis, C., Merritt, A., and research assistants, Burnside, A., Cross, H., Gale, S., and Tahtalian, S. Participants for this study were sourced, in part, through the Australian Schizophrenia Research Bank (ASRB), which is supported by the National Health and Medical Research Council of Australia (Enabling Grant N. 386500), the Pratt Foundation, Ramsay Health Care, the Viertel Charitable Foundation and the Schizophrenia Research Institute. We thank the Chief Investigators and ASRB Manager: Carr, V., Schall, U., Scott, R., Jablensky, A., Mowry, B., Michie, P., Catts, S., Henskens, F., Pantelis, C., Loughland, C. We acknowledge the help of Jason Bridge for ASRB database queries. M. M. was supported by a Cooperative Research Center for Mental Health Top-up Scholarship. S. S. was supported by One-in-Five Association Incorporated. C. S. W. is supported by Schizophrenia Research Institute (utilizing infrastructure funding from the NSW Ministry of Health and the Macquarie Group Foundation), the University of New South Wales, and Neuroscience Research Australia. C. S. W. is a recipient of a National Health and Medical Research Council (Australia) Principal Research Fellowship (PRF) (# 1117079). C. P. was supported by an NHMRC Senior Principal Research Fellowship (628386 & 1105825), and a Brain and Behavior Research Foundation (NARSAD) Distinguished Investigator Award. C. B. was supported by a NHMRC Career Development Fellowship (1127700) and Brain and Behavior Research Foundation (NARSAD) Young Investigator Award (20526). None of the funding sources played any role in the study design; collection, analysis or interpretation of data; in the writing of the report; or in the decision to submit the paper for publication.